VEA
PRVL

Virtus ETF Advisers’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Virtus ETF Advisers’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,601
Closed -$544K – 415
2020
Q4 		$544K Buy
23,601
+3,828
+19% +$88.2K 0.23% 134
2020
Q3 		$201K Sell
19,773
-2,687
-12% -$27.3K 0.11% 299
2020
Q2 		$335K Buy
+22,460
New +$335K 0.16% 280